Lidocaine 5% patch 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F5QXV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,381
Award facts
- Contract value 100% obligated
- $6,381.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., received a competitively awarded delivery order from the Defense Logistics Agency (DLA) on January 7, 2026, for Lidocaine 5% Patch 30-count units with a firm fixed price ceiling value of $6,381.31 and an ultimate completion date of January 8, 2026. The contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Lidocaine patches are topical anesthetic products commonly used for localized pain relief and are essential components of military and veteran healthcare pharmaceutical inventories.
This delivery order is issued under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive prime vendor agreement enables the company to supply a broad range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, syringes, and test kits—to support military healthcare programs globally. Amerisourcebergen, through its parent company Cencora, Inc., serves as a critical supplier for the Defense Health Agency and other federal healthcare systems, demonstrating significant capability in fulfilling government requirements across multiple therapeutic domains and procurement scales.
Quick answers
Who was awarded contract SPE2DR26F5QXV?
SPE2DR26F5QXV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F5QXV worth?
The government has obligated $6,381 on SPE2DR26F5QXV.
Is contract SPE2DR26F5QXV an order under another contract?
Yes. SPE2DR26F5QXV is a delivery order under SPE2DR25D2013, an indefinite delivery contract.
Was contract SPE2DR26F5QXV competed?
The extent of competition for SPE2DR26F5QXV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award